Medtronic and Abbott are both strong dividend-paying medical device companies, but Medtronic currently offers a higher dividend yield of 3.11% and stronger near-term growth prospects, including accelerating revenue and a planned diabetes business separation. Abbott, with a 2.4% yield, boasts a longer streak of dividend increases (54 years) and a more diversified business including diagnostics and pharmaceuticals, supported by its recent $21 billion Exact Sciences acquisition. Medtronic trades at a lower valuation, making it a better choice for income-focused retirees, while Abbott suits investors seeking long-term growth and stability. The decision hinges on income needs versus growth and quality preferences.
Medtronic announced that its Stealth AXiS™ surgical system and Corsano™ multi-parameter wearable have been named to the TIME Best Inventions of 2026 list. The Stealth AXiS™ integrates planning, navigation, and robotic-assisted surgery into one platfo...
MiniMed announced its new Board of Directors following its separation from Medtronic, marking its start as an independent public company focused on diabetes technology. The board includes experts in healthcare, medtech, manufacturing, and governance,...
Procter & Gamble leads with 70 consecutive years of dividend increases, joined by T. Rowe Price, Cisco Systems, Medtronic, and Johnson & Johnson, all known for steady dividend growth backed by strong cash flow. These companies maintain payout ratios ...
Medtronic, Becton Dickinson, and Abbott Laboratories are three healthcare stocks with modest yields that have consistently raised dividends for decades, even through economic downturns. Medtronic is nearing 50 years of dividend increases with a 3.06%...
MiniMed has officially separated from Medtronic, marking its first day as an independent company focused on advancing diabetes care. Medtronic exchanged its shares for MiniMed stock and no longer holds equity in MiniMed. This independence allows Mini...
